Virtual Reality Versus Traditional Exercise on EMG Activity in Postural Malalignment
Public ClinicalTrials.gov record NCT07854678. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Influence of Virtual Reality Versus Traditional Exercise on Trapezius Muscle EMG Activity in Relaxed and Corrected Postures Among Individuals With and Without Postural Malalignment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to investigate the immediate effects of virtual reality (VR)-based exercise compared with traditional Active free exercise on trapezius muscle activation in adults with and without postural malalignment. Surface electromyography (EMG) will be used to assess upper, middle, and lower trapezius muscle activity during relaxed and corrected postures and during VR and traditional exercise. Demographic data will be collected. The study will also assess posture, trapezius muscle strength, cervical range of motion, Activity level, craniovertebral angle, and neck proprioception. Approximately 40 adults aged 18-35 years will participate in a single study session. The findings may help determine whether VR-based rehabilitation provides an effective and engaging approach for assessing and training postural control and trapezius muscle activation.
Study identification
- NCT ID
- NCT07854678
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2026 (Estimated)
- Primary completion
- Aug 25, 2027 (Estimated)
- Completion
- Oct 25, 2027 (Estimated)
- Last update posted
- Oct 2, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hofstra University | Hempstead | New York | 11549 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07854678, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07854678 live on ClinicalTrials.gov.